Carregant...
Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries
BACKGROUND: For the first time in almost 50 years, there are new drugs available for the treatment of tuberculosis (TB), including bedaquiline (BDQ) and delamanid (DLM). The rate of introduction, however, has not kept pace with patient needs. It is estimated that as many as 23% of multidrug-resistan...
Guardat en:
| Publicat a: | Int J Tuberc Lung Dis |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5664221/ https://ncbi.nlm.nih.gov/pubmed/28234080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.16.0493 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|